Luqmani R - Search Results

1

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis.

Suppiah R, Mukhtyar C, Flossmann O, Alberici F, Baslund B, Batra R, Brown D, Holle J, Hruskova Z, Jayne DR, Judge A, Little MA, Palmisano A, Stegeman C, Tesar V, Vaglio A, Westman K, Luqmani R. Suppiah R, et al. Among authors: luqmani r. Rheumatology (Oxford). 2011 May;50(5):899-905. doi: 10.1093/rheumatology/keq400. Epub 2010 Dec 13. Rheumatology (Oxford). 2011. PMID: 21156667 Free article.

2

Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis.

Janssen BA, Luqmani RA, Gordon C, Hemingway IH, Bacon PA, Gearing AJ, Emery P. Janssen BA, et al. Among authors: luqmani ra. Br J Rheumatol. 1994 Dec;33(12):1112-6. doi: 10.1093/rheumatology/33.12.1112. Br J Rheumatol. 1994. PMID: 7528085

3

VITAL (Vasculitis Integrated Assessment Log) assessment of vasculitis.

Bacon PA, Moots RJ, Exley A, Luqmani R, Rasmussen N. Bacon PA, et al. Among authors: luqmani r. Clin Exp Rheumatol. 1995 Mar-Apr;13(2):275-8. Clin Exp Rheumatol. 1995. PMID: 7656482 Clinical Trial. No abstract available.

4

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D. Luqmani RA, et al. QJM. 1994 Nov;87(11):671-8. QJM. 1994. PMID: 7820541

5

Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides.

Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, Adu D. Exley AR, et al. Among authors: luqmani ra. Arthritis Rheum. 1997 Feb;40(2):371-80. doi: 10.1002/art.1780400222. Arthritis Rheum. 1997. PMID: 9041949

6

Assessing disease activity in the systemic vasculitides.

Luqmani RA. Luqmani RA. Curr Opin Rheumatol. 2002 Jan;14(1):23-8. doi: 10.1097/00002281-200201000-00005. Curr Opin Rheumatol. 2002. PMID: 11790992 Review.

7

Diagnosis and assessment of systemic vasculitis.

McLaren JS, McRorie ER, Luqmani RA. McLaren JS, et al. Among authors: luqmani ra. Clin Exp Rheumatol. 2002 Nov-Dec;20(6):854-62. Clin Exp Rheumatol. 2002. PMID: 12508782 Review.

8

Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.

Mukhtyar C, Luqmani R. Mukhtyar C, et al. Among authors: luqmani r. Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv31-6. doi: 10.1136/ard.2005.042416. Ann Rheum Dis. 2005. PMID: 16239383 Free PMC article. Review.

9

Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7.

Merkel PA, Seo P, Aries P, Neogi T, Villa-Forte A, Boers M, Cuthbertson D, Felson DT, Hellmich B, Hoffman GS, Jayne DR, Kallenberg CG, Krischer J, Mahr A, Matteson EL, Specks U, Luqmani R, Stone J; Vasculitis Clinical Research Consortium; OMERACT 7 Special Interest Group. Merkel PA, et al. Among authors: luqmani r. J Rheumatol. 2005 Dec;32(12):2488-95. J Rheumatol. 2005. PMID: 16331794 Review.

10

The role of biologic therapies in the management of systemic vasculitis.

Chan AT, Flossmann O, Mukhtyar C, Jayne DR, Luqmani RA. Chan AT, et al. Among authors: luqmani ra. Autoimmun Rev. 2006 Apr;5(4):273-8. doi: 10.1016/j.autrev.2006.01.003. Epub 2006 Feb 20. Autoimmun Rev. 2006. PMID: 16697969 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

281 results

Search Page